Zanini M

Idioma: Portugués
Referencias bibliográficas: 10
Paginas: 39-40
Archivo PDF: 150.21 Kb.

RESUMEN

Sin resumen

REFERENCIAS (EN ESTE ARTÍCULO)

1. 1.Riccardi VM. Neurofibromatosis: clinical heterogeneity. Curr Probl Cancer 1982;7:1-34.

2. 2.Enziger FM, Weiss SN: Benign tumors of peripheral nerves. En: Soft Tissue Tumors. 3rd ed. St. Louis, Mosby, 1995:821-88.

3. Hager CM, Cohen PR, Tschen JA. Segmental neurofibromatosis: case reports and review. Am J Acad Dermatol 1997;37:864-9.

4. 4.Miller RM, Sparkes RS. Segmental neurofibromatosis. Arch Dermatol 1977;113:837-8.

5. 5.Schwarz J J, Belzberg AJ. Malignant peripheral nerve sheat tumors in the setting of segmental neurofibromatosis. J Neurosurg 2000;92:342-6.

6. 6.Happle R. A rule concerning the segmental manifestation of autosomal dominant skin disorders. Review of clinical examples providing evidence for dichotomous types of severity. Arch Dermatol 1997;133:1505-9.

7. 7.Ruggieri M. The clinical and diagnostic implications of mosaicism in the neurofibromatosis. Neurology 2001;56:1433-43.

8. 8.Moreno JC, Mathoret C, LantieriL, Zeller J, Revuz J, Wolkenstein P. Carbon dioxide laser for removal of multiple cutaneous neurofibromas. Br J Dermatol 2001;144:1096-98.

9. 9.Kajimoto A, Oiso N, Fukai K, Ishii M. Bilateral segmental neurofibromatosis with gastric carcinoma. Clin Exp Dermatol 2007;32:43-4.

10. 10.Consoli C, Moss C, Green S, Balderson D, Cooper DN, Upadhyaya M. Gonosomal mosaicism for a nonsense mutation (R1947X) in the NF1 gene in segmental neurofibromatosis type 1. J Invest Dermatol 2005;125:463-6.